Your browser doesn't support javascript.
loading
Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study.
Yoshida, Chikashi; Yamaguchi, Hiroki; Doki, Noriko; Murai, Kazunori; Iino, Masaki; Hatta, Yoshihiro; Onizuka, Makoto; Yokose, Norio; Fujimaki, Katsumichi; Hagihara, Masao; Oshikawa, Gaku; Murayama, Kayoko; Kumagai, Takashi; Kimura, Shinya; Najima, Yuho; Iriyama, Noriyoshi; Tsutsumi, Ikuyo; Oba, Koji; Kojima, Hiroshi; Sakamaki, Hisashi; Inokuchi, Koiti.
Afiliação
  • Yoshida C; Department of Hematology, National Hospital Organization Mito Medical Center, 280 Sakuranosato, Ibarakimachi, Higashiibarakigun, Ibaraki, 311-3193, Japan. c.yoshida@mitomedical.org.
  • Yamaguchi H; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Murai K; Department of Hematology, Iwate Prefectural Central Hospital, Morioka, Japan.
  • Iino M; Department of Medical Oncology, Yamanashi Prefectural Central Hospital, Kofu, Japan.
  • Hatta Y; Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Yokose N; Department of Hematology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.
  • Fujimaki K; Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan.
  • Hagihara M; Department of Hematology, EIJU General Hospital, Taito-Ku, Japan.
  • Oshikawa G; Japanese Red Cross Musashino Hospital, Musashino, Japan.
  • Murayama K; Division of Hematology, Gunma Prefectural Cancer Center, Ohta, Japan.
  • Kumagai T; Department of Hematology, Ome Municipal General Hospital, Ome-Shi, Tokyo, Japan.
  • Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Iriyama N; Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Tsutsumi I; Department of Hematology, National Hospital Organization Mito Medical Center, 280 Sakuranosato, Ibarakimachi, Higashiibarakigun, Ibaraki, 311-3193, Japan.
  • Oba K; Department of Biostatistics, The University of Tokyo, Tokyo, Japan.
  • Kojima H; Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital, Kasama, Japan.
  • Sakamaki H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Inokuchi K; Department of Hematology, Nippon Medical School, Tokyo, Japan.
Int J Hematol ; 117(5): 694-705, 2023 May.
Article em En | MEDLINE | ID: mdl-36739328
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Duração da Terapia / Antineoplásicos Tipo de estudo: Guideline Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Duração da Terapia / Antineoplásicos Tipo de estudo: Guideline Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão